| Application no. and date | 17754226.3 (espacenet) (Federated) (European Patent Register), 20170728 | | Patent/reg. no. and date | DK/EP 3490560, 20250122 | | Publication date | 20190605 | | Priority no. and date | US 201662368466 P, 20160729, US 201662369239 P, 20160801 | | EP pub. no. and date |
EP 3490560 20190605 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica, N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | | | Inventor | GOTTARDIS, Marco, 9 Harris Road
Princeton
New Jersey 08540, US,
HAWKINS, Rebecca, 1400 McKean Road
Spring House
19477, PA,
SNYDER, Linda, 1400 McKean Road
Spring House
Pennsylvania 19477, US,
YAMADA, Douglas H., 1400 McKean Road
Spring House
Pennsylvania 19477, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61P 35/00 (2006.01) | | Title | NIRAPARIB TIL ANVENDELSE I EN FREMGANGSMÅDE TIL BEHANDLING AF PROSTATACANCER | | Int. application no. | US2017044413 | | Int. publication no. | WO2018023017 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
